Cheryl Klaiman, PhD
Department of Pediatrics
Emory University School of Medicine
Director, Assessment and Diagnosis
Marcus Autism Center
Children’s Healthcare of Atlanta
Cheryl Klaiman, PhD, has been working in the field of autism spectrum disorder (ASD) since 1993 and joined Marcus Autism Center and Emory University in 2012. She is Director for Assessment and Diagnosis Program at Marcus Autism Center, leading a team of 15 clinicians to conduct diagnostic evaluations for clinical and research patients. She is also clinical director of a multisite, U.S. Food and Drug Administration (FDA)-regulated clinical trial working to translate our research endeavors into a tool for diagnosing autism. Dr. Klaiman is also Assessment Core Director for the center’s National Institutes of Health (NIH) Center of Excellence grants.
Dr. Klaiman's research interests center around techniques to aid in the differential diagnosis of individuals with autism, such as eye-tracking, ERP and functional MRI, early diagnosis and treatment strategies, and genetic comorbidities, such as fragile X syndrome and Williams syndrome.